Stockscreener 앱 받기
2.66
3.97%
-0.11
시간 외 거래:
2.67
0.010
+0.38%
전일 마감가:
$2.77
열려 있는:
$2.75
하루 거래량:
447.81K
Relative Volume:
1.07
시가총액:
$175.67M
수익:
$3.64M
순이익/손실:
$-132.20M
주가수익비율:
-0.8924
EPS:
-2.9806
순현금흐름:
$-51.17M
1주 성능:
-31.97%
1개월 성능:
-10.74%
6개월 성능:
+87.32%
1년 성능:
+12.24%
1일 변동 폭
$2.66
$2.8955
1주일 범위
$2.66
$4.12
52주 변동 폭
$1.09
$4.1907
Cibus Inc Stock (CBUS) Company Profile
명칭
Cibus Inc
전화
(858) 450-0008
주소
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
2.66 | 182.93M | 3.64M | -132.20M | -51.17M | -2.9806 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-29 | 개시 | Alliance Global Partners | Buy |
| 2024-07-19 | 재개 | Canaccord Genuity | Buy |
| 2023-10-09 | 개시 | H.C. Wainwright | Buy |
| 2023-07-19 | 재개 | Canaccord Genuity | Buy |
Cibus Inc 주식(CBUS)의 최신 뉴스
Cibus, Inc. (NASDAQ:CBUS) Q4 2025 earnings call transcript - MSN
Cibus, Inc. (NASDAQ:CBUS) Q4 2025 Earnings Call Transcript - Insider Monkey
Cibus, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Cibus, Inc. Earnings Call Signals Promise Amid Pressure - TipRanks
Cibus Q4 Earnings Call Highlights - MarketBeat
Cibus (CBUS) Q4 2025 Earnings Call Transcript - AOL.com
Cibus Inc: Sr VP Sauer sells $5 in stock By Investing.com - Investing.com India
Cibus (CBUS) CFO logs small 1,496-share tax-withholding disposition - Stock Titan
Cibus (CBUS) SVP reports minor share sale and tax withholding - Stock Titan
Cibus (NASDAQ: CBUS) CLO reports 13,109-share tax-withholding dispositions - Stock Titan
Cibus Inc. Accelerates Crop Productivity with Proprietary Gene Editing Technologies and Rapid Trait Development System (RTDS) - Minichart
Cibus Inc (CBUS) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada
Cibus targets $200M annual rice royalties with expanded Latin America and India push while advancing biofragrance commercialization - MSN
Cibus Inc (CBUS) Q4 2025 Earnings Call Highlights: Strategic Adv - GuruFocus
Cibus reports Q4 EPS (59c) vs. (87c) last year - TipRanks
Cibus (CBUS) Sets Sights on Global Expansion with Promising Rice Program - GuruFocus
Cibus (CBUS) Reports Lower Q4 Revenue Amid Strategic Developments - GuruFocus
Cibus: 2025 Landmark Year in Gene Editing Commercialization & EU Regulatory ShiftNews and Statistics - IndexBox
Earnings call transcript: Cibus Q4 2025 shows cost cuts, stock up By Investing.com - Investing.com India
Cibus Inc’s 2025 Earnings Call: EU Gene Editing Timelines and Biofragrance Revenue Roadmaps Clash - Bitget
Cibus (CBUS) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Earnings call transcript: Cibus Q4 2025 shows cost cuts, stock up - Investing.com
Cibus (NASDAQ:CBUS) Releases Earnings Results, Misses Expectations By $0.16 EPS - MarketBeat
Cibus: Q4 Earnings Snapshot - marketscreener.com
Cibus Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cibus 2025 10-K: Revenue $3.6M, EPS loss $2.78 - TradingView
Cibus (NASDAQ: CBUS) doubles down on gene-edited rice traits amid funding risk - Stock Titan
Cibus Reports Fourth Quarter Financial Results and Provides Business Update - The Manila Times
Cibus reports Q4 net loss $31.9M, revenue $1.06M; cash $9.9M at Dec 31, 2025 - TradingView
Cibus, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Cibus (NASDAQ: CBUS) posts wider Q4 loss and sees cash runway into Q3 2026 - Stock Titan
Cibus Global Inc options imply 19.8% move in share price post-earnings - TipRanks
Cibus (CBUS) Fourth Quarter 2025 Earnings Conference Call Transcript - Bitget
Cibus Inc expected to post a loss of 43 cents a shareEarnings Preview - TradingView
CBUS Stock Price and Chart — NASDAQ:CBUS - TradingView
Cibus (CBUS) Projected to Post Earnings on Tuesday - MarketBeat
CBUS Earnings History & Surprises | EPS & Revenue Results | CIBUS INC (NASDAQ:CBUS) - ChartMill
Cibus, Inc. (NASDAQ:CBUS) Q3 2025 Earnings Call Transcript - MSN
ETF Watch: How is Cibus Inc managing supply chain issuesJuly 2025 Breakouts & Community Driven Trade Alerts - baoquankhu1.vn
Market Outlook: Why Cibus Inc. stock appeals to analysts2025 Institutional Moves & Low Risk High Reward Ideas - Naître et grandir
Cibus to Report Fourth Quarter 2025 Financial Results on - GlobeNewswire
Cibus to Report Fourth Quarter 2025 Financial Results on March 17, 2026 After the Market Close and Host Conference Call - The Globe and Mail
CBUS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cibus Target of Unusually High Options Trading (NASDAQ:CBUS) - MarketBeat
Cibus Advancing GMO Alternative - San Diego Business Journal
Short Interest in Cibus, Inc. (NASDAQ:CBUS) Increases By 46.1% - MarketBeat
Is Cibus Inc. stock a falling knife or bargain buyAnalyst Downgrade & Real-Time Price Movement Reports - mfd.ru
FMR LLC Reduces Stake in Cibus Inc: Analyzing the Implications - GuruFocus
Cibus (NASDAQ:CBUS) Shares Down 1.4%Time to Sell? - MarketBeat
Targets Report: Whats the RSI of Cibus Inc stockMarket Activity Summary & Safe Capital Growth Tips - baoquankhu1.vn
Cibus Participates in UK Government-Funded Precision Breeding Project for Oilseed Rape - iGrow News
Cibus Inc (CBUS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):